Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft versus host disease after allogeneic stem cell transplantation for acquired aplastic anemia.

    ... (n=29), using fludarabine 30mg/m(2) for 4 days, cyclophosphamide 300mg/m(2) for 4 days and alemtuzumab median total dose ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Cyclophosphamide

    ... [TODO] This content is all filler.  Please replace. Cyclophosphamide ( INN ), also known as cytophosphane, is a medication ... forming intrastrand and interstrand DNA crosslinks . Cyclophosphamide is used to treat cancers , autoimmune disorders , and ...

    Drug last updated 03/24/2016 - 12:32pm.

  3. Cyclophosphamide in severe aplastic anemia?

    Journal Title:  Blood Primary Author:  Peffault de Latour R Author(s):  Peffa...

    Research Article last updated 07/20/2018 - 5:15pm.

  4. Less could be better: The case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia.

    Journal Title:  Pediatr Transplant Primary Author:  Hussein AA Author(s):  Hu...

    Research Article last updated 07/20/2018 - 5:15pm.

  5. Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia

    ... rabbit antithymocyte globulin (r-ATG) or cyclophosphamide is not known. We investigated standard horse ATG (h-ATG) ... who were refractory to initial r-ATG/CsA (n=19) or cyclophosphamide/CsA (n=6) (registered at clinicaltrials.gov as NCT00944749). ...

    Research Article last updated 07/20/2018 - 5:15pm.

  6. Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels

    ... adverse events were encountered in a Phase I/II study of cyclophosphamide (CY) dose deescalation in a fludarabine -based ...

    Research Article last updated 07/20/2018 - 5:14pm.

  7. Engraftment of heavily transfused patients with severe aplastic anemia with a fludarabine-based regimen

    ... The application of ATG, Busulphan, and/or irradiation to cyclophosphamide (Cy) to avoid graft rejection has many short- and ... treated with fludarabine (40 mg/m(2) /d; day [-5 to -2]) and cyclophosphamide (50 mg/kg/d; day [-5 to -2]). Altogether, 81 patients ...

    Research Article last updated 07/20/2018 - 5:15pm.

  8. Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia

    ... years). Transplantation-preparative regimes were mostly cyclophosphamide with or without antithymocyte globulin . Survival ... among those who received total body irradiation. Cyclophosphamide recipients demonstrated normal growth, basically normal ...

    Research Article last updated 07/20/2018 - 5:14pm.

  9. Matched sibling donor hematopoietic stem cell transplant in patients with acquired aplastic anemia

    ... as possible with a bone marrow graft, conditioned with cyclophosphamide and ATG and treated with CSA and MTX as GvHD prophylaxis. ...

    Research Article last updated 07/20/2018 - 5:15pm.

  10. Non-myeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia

    ... reduced-intensity conditioning with postgraft high-dose cyclophosphamide in 8 patients with refractory SAA or patients who ...

    Research Article last updated 07/20/2018 - 5:15pm.